4-(4-(1-(3-ETHYLBENZO(D)THIAZOL-2(3H)-YLIDENE)PROPAN-2-YLIDENE)-3-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOL-1-YL)BENZENESULFONICT
UNII SU5S3DS21U
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-(1-(3-ethylbenzo(d)thiazol-2(3h)-ylidene)propan-2-ylidene)-3-methyl-5-oxo-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonict, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SU5S3DS21U.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 31994-53-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H21N3O4S2 BGUFNHOQYFNSKN-NMGXZBPKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-(1-(3-ethylbenzo(d)thiazol-2(3h)-ylidene)propan-2-ylidene)-3-methyl-5-oxo-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonict. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.